Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Clinical trial NCT04802733 · COMPLETED
Trial details
- NCT number
- NCT04802733
- Sponsor
- BlueRock Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2023-05-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.